Cargando…
Changes in Expression of DNA-Methyltransferase and Cannabinoid Receptor mRNAs in Blood Lymphocytes After Acute Cannabis Smoking
BACKGROUND: Cannabis use is a component risk factor for the manifestation of schizophrenia. The biological effects of cannabis include effects on epigenetic systems, immunological parameters, in addition to changes in cannabinoid receptors 1 and 2, that may be associated with this risk. However, the...
Autores principales: | Smith, Robert C., Sershen, Henry, Janowsky, David S., Lajtha, Abel, Grieco, Matthew, Gangoiti, Jon A., Gertsman, Ilya, Johnson, Wynnona S., Marcotte, Thomas D., Davis, John M. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Frontiers Media S.A.
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9290435/ https://www.ncbi.nlm.nih.gov/pubmed/35859599 http://dx.doi.org/10.3389/fpsyt.2022.887700 |
Ejemplares similares
-
Deficits in odor discrimination versus odor identification in patients with schizophrenia and negative correlations with GABAergic and DNA methyltransferase mRNAs in lymphocytes
por: Smith, Robert C., et al.
Publicado: (2023) -
Investigating Relationships Between Alcohol and Cannabis Use in an Online Survey of Cannabis Users: A Focus on Cannabinoid Content and Cannabis for Medical Purposes
por: Karoly, Hollis C., et al.
Publicado: (2020) -
Cannabinoids in the Treatment of Cannabis Use Disorder: Systematic Review of Randomized Controlled Trials
por: Vuilleumier, Caroline, et al.
Publicado: (2022) -
Contemplating cannabis? The complex relationship between cannabinoids and hepatic metabolism resulting in the potential for drug-drug interactions
por: Smith, Rosemary T., et al.
Publicado: (2023) -
A Comparison of Acute Neurocognitive and Psychotomimetic Effects of a Synthetic Cannabinoid and Natural Cannabis at Psychotropic Dose Equivalence
por: Theunissen, Eef Lien, et al.
Publicado: (2022)